No black box warning on record for Gemfibrozil

As of the latest FDA labeling reviewed, Gemfibrozil (GEMFIBROZIL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Gemfibrozil medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS 1. Because of chemical, pharmacological, and clinical similarities between gemfibrozil and clofibrate, the adverse findings with clofibrate in two large clinical studies may also apply to gemfibrozil. In the first of those studies, the Coronary Drug Project, 1,000 subjects with previous myocardial infarction were treated for five years with clofibrate. There was no difference in mortality

No black box warning on record for Gemfibrozil

Other warnings & precautions

WARNINGS 1. Because of chemical, pharmacological, and clinical similarities between gemfibrozil and clofibrate, the adverse findings with clofibrate in two large clinical studies may also apply to gemfibrozil. In the first of those studies, the Coronary Drug Project, 1,000 subjects with previous myocardial infarction were treated for five years with clofibrate. There was no difference in mortality

Gemfibrozil Black Box Warning

No black box warning on record for Gemfibrozil

Other warnings & precautions

Gemfibrozil Black Box Warning

No black box warning on record for Gemfibrozil

Other warnings & precautions